Plasma Ceramides Predict All-Cause and Cause-Specific Mortality in Individuals With Type 2 Diabetes
The Journal of Clinical Endocrinology & Metabolism · 22.04.2025 · 110 (5) · 1497-1504
DOI: 10.1210/clinem/dgae388 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 08.06.2024. Verfasst von Sylvia Liu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Republic of Singapore 768828. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Ceramides, Cardiovascular Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Singapore National Medical Research Council.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Context
The Cardiovascular Event Risk Test (CERT1) score derived from plasma ceramides has been applied clinically for cardiovascular risk assessment.
Objective
To study whether plasma ceramides predict risk of mortality in patients with type 2 diabetes.
Methods
In a prospective study that included 1903 outpatients with type 2 diabetes in a regional hospital and a primary care facility in Singapore, plasma ceramides (d18:1/16:0, d18:1/18:0, d18:1/24:0, d18:1/24:1) were measured by mass spectrometry and CERT1 score was calculated accordingly. Main outcomes were all-cause and cause-specific mortality.
Results
During a median of 9.3 years of follow-up, 252 death events were identified. Compared to those with low score (≤ 2), participants with a high CERT1 score (≥ 7) had 1.86-fold (95% CI, 1.30-3.65) increased risk for all-cause death after adjustment for cardiorenal risk factors, including estimated glomerular filtration rate and albuminuria. As continuous variable, 1-unit increment in CERT1 was associated with 8% increased risk for all-cause death (adjusted hazard ratio [HR] 1.08 [1.04-1.13]). Adding CERT1 onto Risk Equations for Complications Of type 2 Diabetes (RECODe) mortality risk engine significantly improved prediction of 10-year risk of all-cause death (area under the curve, 0.810 to 0.823, delta 0.013 [0.005-0.022]). The association between CERT1 and noncardiovascular death remained significant (adjusted HR 2.12 [1.32-3.42]), whereas its association with cardiovascular death became nonsignificant after adjustment for kidney measurements (adjusted HR 1.41 [0.78-2.56]).
Conclusion
CERT1 score predicts mortality risk independent of clinical cardiorenal risk factors. Further studies are warranted to elucidate the mechanistic linkage between ceramide and mortality, especially noncardiovascular mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Research Unit, Khoo Teck Puat Hospital, Singapore, Republic of Singapore 768828.
- Precision Medicine Translational Research Programme and Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore 119077.
- Singapore Lipidomics Incubator, Life Sciences Institute, National University of Singapore, Singapore, Republic of Singapore 119077.
- DUKE-NUS Medical School, Cardiovascular and Metabolic Disorders Signature Research Program, Singapore, Republic of Singapore 169857.
- Diabetes Centre, Admiralty Medical Centre, Singapore, Republic of Singapore 730676.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Republic of Singapore 308232.
ORCID-Profile: Su Chi Lim
Förderung
- Singapore National Medical Research Council
Zitieren
APA
Liu, S., Tham, W. K., Lee, J., Ang, K., Zheng, H., Chan, C., Gurung, R. L., Tavintharan, S., Sum, C. F., Wenk, M. R., Torta, F., Liu, J. J., & Lim, S. C. (2025). Plasma Ceramides Predict All-Cause and Cause-Specific Mortality in Individuals With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism, 110(5), 1497-1504. https://doi.org/10.1210/clinem/dgae388
Vancouver
Liu S, Tham WK, Lee J, Ang K, Zheng H, Chan C, et al. Plasma Ceramides Predict All-Cause and Cause-Specific Mortality in Individuals With Type 2 Diabetes. The Journal of Clinical Endocrinology & Metabolism. 2025;110(5):1497-1504. doi:10.1210/clinem/dgae388
BibTeX
@article{Liu2025,
author = {Liu, Sylvia and Tham, Wai Kin and Lee, Janus and Ang, Keven and Zheng, Huili and Chan, Clara and Gurung, Resham L and Tavintharan, Subramaniam and Sum, Chee Fang and Wenk, Markus R and Torta, Federico and Liu, Jian-Jun and Lim, Su Chi},
title = {Plasma Ceramides Predict All-Cause and Cause-Specific Mortality in Individuals With Type 2 Diabetes},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
volume = {110},
number = {5},
pages = {1497--1504},
doi = {10.1210/clinem/dgae388}
}
EUVIMED